The American Heart Association (AHA) Scientific Sessions 2022 in Chicago, and virtually, is set for November 5-7 at McCormick Place. Highly-anticipated clinical trial breakthroughs and discoveries of the year will be offered in both late-breaking scientific sessions and featured science sessions.

Related Keywords

China , Boston , Massachusetts , United States , Mccormick Place , Illinois , Chicago , Chinese , American , Nancy Brown , Juanf Granada , American Heart Association , Office Blood Pressure , Electronic Health Record , Cardiovascular Research Foundation , Scientific Sessions , Pre Session Symposia , Early Career Day , Special Lectures , Council Awards , Named Lectures , Distinguished Achievement , Best Abstract , Early Career Abstract , Heart Theater , Learning Studios , Puppy Snuggle Zone , Breaking Scientific Session , Main Event , Changing Clinical Practice , Comparative Effectiveness , Heart Failure , Primary Results , Chlorthalidone Compared , Cardiovascular Events , Randomized Trial , Triglyceride Reduction , Ttr Gene , Transthyretin Amyloidosis With , Patient Risk Based Health System Intervention , Acute Heart Failure Care , Yearly Results , Patient Reported Outcome Measurement , Heart Failure Clinic , Intravenous Ferric Derisomaltose , Reduced Ejection , Impact Trials , Radial Artery Patency , Clinical Outcomes , Randomized Trials , Year Clinical Outcomes Comparing Radial Artery , Right Internal Thoracic Artery , With Saphenous Vein , Chinese Herbal Medicine , Acute Myocardial Infarction , Results From , Extracorporeal Membrane Oxygenation , Cardiogenic Shock , Chronic Hypertension Management , Cardiovascular Disease Among Patients , Cluster Randomized , Life Project , Reducing Inequities , Lifestyle Improvement , Blood Pressure , Adapted Mindfulness Training , Elevated Office Blood Pressure , Mindfulness Based Blood Pressure Reduction , Randomized Clinical , Quadruple Ultra Low Dose Treatment , Randomized Controlled , Prevent Cardiovascular , Renal Disease , Evaluating Secondary Prevention Efficacy , Combination Therapy , With Small Interfering , Cardiovascular Outcomes , Chronic Kidney Disease , Low Dose Statin Compared , Six Dietary Supplements , Inflammatory Biomarkers , Bivalirudin With , Dose Infusion , Precision Care Strategy , Usual Testing , Guide Management , Precise Randomized , Follow Up Interim , Limb Loss Through Vascular Interventions , Venous Therapies , Best Endovascular , Best Surgical Therapy , Chronic Limb Threatening Ischemia , Major Venous , Arterial Thrombotic Events , Medically Ill Outpatients , Multicenter Clustered Randomized Trial , Integrated Clinical Decision Support , Hospitalized Medically Ill , Supraventricular Arrhythmias , Atrial Fibrillation Progression , Self Administered Etripamil , Primary Analysis , Botulinum Toxin Type , Postoperative Atrial Fibrillation , Cardiac Surgery Patients , Clinical Trial , Pressure Cooker , Top Line Results , Treatment Resistant Hypertension , Sustained Blood Pressure Lowering Effect , Dual Endothelin Receptor Antagonist Aprocitentan , Resistant Hypertension , Controlled Study Including , Placebo Controlled Trial Evaluating , Radiofrequency Renal Denervation , Antihypertensive Drugs , Month Primary Results , Fresh Look , Heart Rhythm , Best Practices , Executive Officer , Chief Executive Officer ,